http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6121301-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c0ba7037f9003fddd25919eee4a97a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 |
| filingDate | 1997-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a521bcb6443409d47b9719f2f6cc703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_374edb7a1f1abfbb4593027668414f50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4ab280e0039d447e543791746f646cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba308a978df67558082d862ec5b0f180 |
| publicationDate | 2000-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6121301-A |
| titleOfInvention | Substituted benzoylaminothiazole derivatives and drugs containing the same |
| abstract | PCT No. PCT/JP97/03774 Sec. 371 Date Apr. 21, 1999 Sec. 102(e) Date Apr. 21, 1999 PCT Filed Oct. 20, 1997 PCT Pub. No. WO98/17654 PCT Pub. Date Apr. 30, 1998The present invention relates to a substituted benzoylaminothiazole derivative represented by the following formula (I): wherein X represents an imino group which may be substituted by a lower alkyl group, or an oxygen atom, R1 represents a cyano group, a lower alkoxycarbonyl group, a lower alkoxycarbonylamino group, a lower alkylsulfonylamino group, a lower alkanoyl or lower alkylsulfonyl group which may be substituted by a halogen atom, a 1-ureido group, a halo-substituted lower alkyl group or a 2-pyrrolylimino group, R2 and R3 are the same or different and each independently represents a hydrogen atom or a lower alkyl group and m stands for an integer of 2 to 4, or a salt thereof; and a medicament comprising the compound as an effective ingredient. The compound of the invention is useful as a preventive and therapeutic agent for epigastric dyscomfort, nausea, vomiting, heartburn, anorexia, bellyache, abdominal flatulence, chronic gastritis or the like. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6986901-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021244770-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673368-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005136127-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004010035-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004013741-A1 |
| priorityDate | 1996-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 578.